Developmental Genotype-Tissue Expression Project vs Mammoth Biosciences
Developmental Genotype-Tissue Expression Project vs Mammoth Biosciences, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Developmental Genotype-Tissue Expression Project is on 51/100 and Mammoth Biosciences on 63/100.
Where each one leads
Developmental Genotype-Tissue Expression Project
Leads on none of the measures we hold for both companies.
Mammoth Biosciences
- our overall score: 63/100 against 51/100
- funding raised: $460M against $38.5M
At a glance
| Measure | Developmental Genotype-Tissue Expression Project | Mammoth Biosciences |
|---|---|---|
| What it is | Establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases. | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. |
| Category | Biotechnology, Healthcare, Genomics, Data Science | Biotechnology, Drug Discovery, Genomics, CRISPR Technology |
| Sells toBusiness model | B2G | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2017 |
| Headquarters | Philadelphia, United States | Brisbane, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Developmental Genotype-Tissue Expression Project | Mammoth Biosciences |
|---|---|---|
| Employees | Not published | 165 |
| Headcount growthLast 12 months | Not published | +5.8% |
| Total funding | $38.5M | $460M |
| Latest round | Grant | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 57,986 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Developmental Genotype-Tissue Expression Project | Mammoth Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 63/100 |
| Traction | 38/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | Not published | 35/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | Not published | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Developmental Genotype-Tissue Expression Project | Mammoth Biosciences |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Developmental Genotype-Tissue Expression Project vs Mammoth Biosciences: common questions
Which is better, Developmental Genotype-Tissue Expression Project or Mammoth Biosciences?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Developmental Genotype-Tissue Expression Project and Mammoth Biosciences compare on the numbers?
Mammoth Biosciences leads on our overall score (63/100 against 51/100), funding raised ($460M against $38.5M).
Read the full Developmental Genotype-Tissue Expression Project review and pricing or the Mammoth Biosciences review and pricing. You can also browse other Developmental Genotype-Tissue Expression Project alternatives we track.